BASILEA.9.pptx

BUSINESS
MODEL
ANALYSIS
CLÉMENT DUBOS
JULIETTE PAILLARD
MARÍA ALCÁZAR DUQUE
SIHEM ALLOTI
SOSSANE NOURESTANI

PRESENTATION MAP
About the company
Governance
Pipeline
Financial statement
SWOT

About The Company
Features
•Headquarter: Basel, Switzerland.
•Innovative pharmaceutical products
Bacterial infections, fungal infections, oncology.
Resistance and nonresponse.
•Founded in 2000 as spin-off of Roche.
•Publicly traded since 2004 on the SIX Swiss Exchange.

About The Company
Basilea
Pharmaceuticals ltd.
Basilea Pharma SAS
Basilea
Pharmaceuticals A/S
Basilea
Pharmaceutica ltd.
Basilea Pharmaceutica
Deutschland gmbh
Basilea Pharmaceutica
China ltd.
Basilea
Pharmaceutica s.r.l.
Basilea Pharmaceuticals
iberia s.l.

About The Company
Research Center In China
-Wholly-owned subsidiary of Basilea
-Near Shangai, Jiangsu Province
People’s Republic of China
-Basilea’s key R&D projects
●Chemical synthesis
●Analytical development
●Process research and development
-Awards:
●High-tech Enterprise
● “A” class for safety operation
●Best Safety Performance
●Development of the local R&D